Evidence map›Paper›PMID 39604349›Full record

SynthesisNature communications2024

Innovative technologies to address neglected tropical diseases in African settings with persistent sociopolitical instability.

Tsegahun Manyazewal, Gail Davey, Charlotte Hanlon, Melanie J Newport, Michael Hopkins, Jenni Wilburn, Sahar Bakhiet, Leon Mutesa, Agumasie Semahegn, Esubalew Assefa and 1 more

Abstract readSystematic Review
In one paragraph

Synthesis in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Tsegahun ManyazewalCenter for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia. tsegahun.manyazewal@aau.edu.et.ORCID 0000-0002-8360-7574
Gail DaveyCentre for Global Health Research, Brighton and Sussex Medical School, Brighton, UK.
Charlotte HanlonCenter for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Melanie J NewportCentre for Global Health Research, Brighton and Sussex Medical School, Brighton, UK.ORCID 0000-0002-8946-7525
Michael HopkinsScience Policy Research Unit, University of Sussex, Brighton, UK.
Jenni WilburnCentre for Global Health Research, Brighton and Sussex Medical School, Brighton, UK.
Sahar BakhietInstitute of Endemic Diseases, University of Khartoum, Khartoum, Sudan.
Leon MutesaCenter for Human Genetics, College of Medicine and Health Sciences, University of Rwanda, Kigali, Rwanda.ORCID 0000-0002-5308-3706
Agumasie SemahegnCenter for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Esubalew AssefaCenter for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Abebaw FekaduCenter for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.ORCID 0000-0003-2219-0952

Funding

DH | National Institute for Health Research (NIHR) 131996
6 · The paper itself

Abstract

The health, economic, and social burden of neglected tropical diseases (NTDs) in Africa remains substantial, with elimination efforts hindered by persistent sociopolitical instability, including ongoing conflicts among political and ethnic groups that lead to internal displacement and migration. Here, we explore how innovative technologies can support Africa in addressing NTDs amidst such instability, through analysis of WHO and UNHCR data and a systematic literature review. Countries in Africa facing sociopolitical instability also bear a high burden of NTDs, with the continent ranking second globally in NTD burden (33%, 578 million people) and first in internal displacement (50%, 31.6 million people) in 2023. Studies have investigated technologies for their potential in NTD prevention, surveillance, diagnosis, treatment and management. Integrating the evidence, we discuss nine promising technologies-artificial intelligence, drones, mobile clinics, nanotechnology, telemedicine, augmented reality, advanced point-of-care diagnostics, mobile health Apps, and wearable sensors-that could enhance Africa's response to NTDs in the face of persistent sociopolitical instability. As stability returns, these technologies will evolve to support more comprehensive and sustainable health development. The global health community should facilitate deployment of health technologies to those in greatest need to help achieve the NTD 2030 Roadmap and other global health targets.

Indexed as

Neglected DiseasesTropical MedicineAfricaArtificial IntelligenceHumansPoliticsTelemedicine

Identifiers

PMID39604349
PMCPMC11603293

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.